Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Alector's consensus analyst price target has recently dropped from $2.20 to $2.05 per share, signaling reduced confidence in the company's near-term outlook. This adjustment comes after the release of ...